GLOW LIFETECH CORP. (9DO) - Net Assets
Based on the latest financial reports, GLOW LIFETECH CORP. (9DO) has net assets worth €3.07 Million EUR (≈ $3.59 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€4.18 Million ≈ $4.89 Million USD) and total liabilities (€1.11 Million ≈ $1.30 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 9DO PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €3.07 Million |
| % of Total Assets | 73.41% |
| Annual Growth Rate | -5.76% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 78.65 |
GLOW LIFETECH CORP. - Net Assets Trend (2021–2025)
This chart illustrates how GLOW LIFETECH CORP.'s net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see GLOW LIFETECH CORP. stock valuation.
Annual Net Assets for GLOW LIFETECH CORP. (2021–2025)
The table below shows the annual net assets of GLOW LIFETECH CORP. from 2021 to 2025. Also explore GLOW LIFETECH CORP. annual equity growth to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €2.71 Million ≈ $3.17 Million |
+5.42% |
| 2024-12-31 | €2.57 Million ≈ $3.01 Million |
+349.29% |
| 2023-12-31 | €-1.03 Million ≈ $-1.21 Million |
-185.04% |
| 2022-12-31 | €1.21 Million ≈ $1.42 Million |
-64.71% |
| 2021-12-31 | €3.44 Million ≈ $4.02 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to GLOW LIFETECH CORP.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 774186200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €21.77 Million | 803.25% |
| Total Equity | €2.71 Million | 100.00% |
GLOW LIFETECH CORP. Competitors by Market Cap
The table below lists competitors of GLOW LIFETECH CORP. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PAVmed Inc
NASDAQ:PAVM
|
$3.66 Million |
|
Earthworks Industries Inc
V:EWK
|
$3.66 Million |
|
Zephyr Minerals Ltd
V:ZFR
|
$3.66 Million |
|
Bio-Gene Technology Ltd
AU:BGT
|
$3.67 Million |
|
Highway Holdings Limited
NASDAQ:HIHO
|
$3.65 Million |
|
ZhongDe Waste Technology AG
F:ZEF
|
$3.65 Million |
|
Vnsteel Vicasa JSC
VN:VCA
|
$3.65 Million |
|
Vinvest Capital Holdings Bhd
KLSE:0069
|
$3.65 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in GLOW LIFETECH CORP.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,570,389 to 2,709,731, a change of 139,342 (5.4%).
- Net loss of 617,861 reduced equity.
- Other factors increased equity by 757,203.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-617.86K | -22.8% |
| Other Changes | €757.20K | +27.94% |
| Total Change | €- | 5.42% |
Book Value vs Market Value Analysis
This analysis compares GLOW LIFETECH CORP.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.41x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.35x to 1.41x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €0.06 | €0.02 | x |
| 2022-12-31 | €0.02 | €0.02 | x |
| 2023-12-31 | €-0.02 | €0.02 | x |
| 2024-12-31 | €0.02 | €0.02 | x |
| 2025-12-31 | €0.01 | €0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently GLOW LIFETECH CORP. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -22.80%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -30.09%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 1.45x
- Recent ROE (-22.80%) is above the historical average (-127.40%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -329.33% | 0.00% | 0.00x | 1.10x | €-11.66 Million |
| 2022 | -181.50% | 0.00% | 0.00x | 1.96x | €-2.32 Million |
| 2023 | 0.00% | -3617.40% | 0.03x | 0.00x | €-1.49 Million |
| 2024 | -103.38% | -317.79% | 0.22x | 1.45x | €-2.91 Million |
| 2025 | -22.80% | -30.09% | 0.52x | 1.45x | €-888.83K |
Industry Comparison
This section compares GLOW LIFETECH CORP.'s net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $685,731,838
- Average return on equity (ROE) among peers: -86.06%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| GLOW LIFETECH CORP. (9DO) | €3.07 Million | -329.33% | 0.36x | $3.66 Million |
| TME PHARM.CONF.IPO EO 1- (0N6A) | $1.61 Million | -354.52% | 1.11x | $10.44 Million |
| PROQR THERAPEUTICS EO-04 (0PQ) | $41.39 Million | -67.94% | 2.33x | $142.34 Million |
| TIZIANA LIFE SCIENCES LTD (0RP) | $3.94 Million | -301.40% | 1.87x | $141.34 Million |
| Theravance Biopharma Inc (0TB) | $-338.57 Million | 0.00% | 0.00x | $828.57 Million |
| I-MAB SPONS.ADS/1 -0001 (0VY) | $421.77 Million | -87.98% | 0.40x | $183.88 Million |
| PreveCeutical Medical Inc (18H) | $-4.10 Million | 0.00% | 0.00x | $3.34 Million |
| Argen-X (1AE) | $5.50 Billion | 15.15% | 0.13x | $41.67 Billion |
| WAVE LIFE SCIENCES LTD. (1U5) | $518.36 Million | -39.43% | 0.23x | $888.51 Million |
| BIOCURE TECHNOLOGY INC. (1WH) | $-852.32K | 0.00% | 0.00x | $960.84K |
| ZAI LAB LTD0000006 (1ZLB) | $715.50 Million | -24.53% | 0.64x | $1.82 Billion |
About GLOW LIFETECH CORP.
Glow Lifetech Corp., an ingredient technology company, focuses on producing nutraceutical and cannabinoid-based products. It engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based capsules, and market-ready products, as well as precision-dosed capsules. The company has exclusive North American rights for the pr… Read more